Perimeter Medical Imaging - FloodGate Medical

Giving surgeons clarity on margins to act
in the moment and close with confidence.

About Us

Perimeter Medical Imaging AI is a medical technology company driven to transform cancer surgery with ultra-high resolution, real-time, advanced imaging tools that address unmet medical needs. A Toronto-based company established in 2013, with U.S. headquarters in Dallas, Texas, Perimeter seeks to harness the power of big data, artificial intelligence, and machine learning technology to further its mission of improving the standard of care, providing better long-term outcomes for patients, and reducing healthcare costs.

Perimeter envisions a world where patients no longer experience the emotional and physical trauma of a second operation due to cancer left behind.

Look at the Leaders of Perimeter Medical Imaging

Adrian Mendes

Chief Executive Officer

Andrew Berkeley

Co-Founder & Chief Innovation Officer

Abbey Goodman

Vice President, Sales

Featured Services and Innovations

S-Series OCT

The Dreaded Call. We Didn’t Get It All.

Cancer surgeons have long recognized the challenge of achieving clean margins while preserving healthy tissue during surgery. Traditional intraoperative imaging does not have the resolution to see microscopic features associated with cellular-level disease, like DCIS.² And it’s several days or weeks before pathology reports on margin status are available. If pathology shows positive margins, patients must typically return for another procedure due to cancer left behind.

Perimeter’s OCT technology delivers the clinical edge healthcare providers need to improve patient satisfaction and offer the most advanced care.

Patient Outcomes in Their Own Words.

Company Spotlight Video

News and Stories

Perimeter Medical Imaging AI Reports Fourth Quarter and Full Year 2024 Financial Results

TORONTO and DALLAS, March 26, 2025 /CNW/ – Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) (“Perimeter” or the “Company”), a commercial-stage medical technology company, today reported financial results for its fourth quarter and full year ended December 31, 2024 and provided a corporate update. Unless specified otherwise, all amounts in this press release are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board.

Perimeter Files FDA PMA Application for its Next-Generation B-Series OCT with ImgAssist AI 2.0

TORONTO and DALLAS, March 17, 2025 /CNW/ – Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) (“Perimeter” or the “Company”), a commercial-stage medical technology company, today announced the submission of a Premarket Approval (“PMA”) application to the U.S. Food and Drug Administration (“FDA”) for the Company’s next-generation Perimeter B-Series OCT system, which combines proprietary artificial intelligence (“AI”) technology with optical coherence tomography (“OCT”), for use during breast-conserving surgeries (“BCS”) in the United States.

Covenant Health Fort Sanders Regional First in Tennessee to Bring Perimeter Medical Imaging AI's Pioneering Technology to Surgery

TORONTO and DALLAS, March 6, 2025 /PRNewswire/ – In advance of International Women’s Day, Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) (“Perimeter” or the “Company”), announced today that Covenant Health Fort Sanders Regional is the first hospital in Tennessee to use the Company’s S-Series OCT (Optical Coherence Tomography) technology to visualize tissue margins in the operating room.

Looking to stand out from the crowd during your job search? Click below to gain access to our top tips & tools for candidates during the hiring process!

Recruiting Done Differently.

Improving lives by uniting great people with great companies.

Sign up for our Monthly Newsletter

We’re committed to sharing up-to-date industry insights, our newest career opportunities, and valuable tools to support you throughout your next job search. Let’s stay connected!

Giving surgeons clarity on margins to act in the moment and close with confidence.